TGFB1 and neoplasm: As loss of this growth-inhibitory response occurs at a level downstream of the core TGFβ signaling pathway, TGFβ then switches to a tumor-progression factor promoting epithelial-to-mesenchymal transition while inhibiting proliferation, differentiation, and the antitumor activity of multiple immune cells (90).